Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Business Wire
#Fisher Scientific#Scientific Prices#Prices Offering#Senior Notes#Business Wire
Life Science News
Latest updates from the biotech and pharma world
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - Business Wire
#Thermo Fisher#Fisher Scientific#Fisher Connect#Scientific Showcases#Connect Platform
Agrigenomics arrays and consortia | Collaborating with experts - Illumina
#Agrigenomics arrays#Illumina Agrigenomics#Collaborating#experts Illumina#consortia
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities | Scientific Reports - Nature
#Scientific Reports#rRNA profiling#microbial communities#Comparative analysis#oxford nanopore
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Synaffix Collaborates#Qurient Therapeutics#ADC Development#Dual-Payload ADC
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
#Pharma Letter#Qurient team#dual-payload ADC#Letter Lonza#Synaffix
RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical
#engages Lonza#RION engages#scale manufacturing#manufacturing exosome#exosome based
Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters
#Novartis underline#Trump pharma#pharma tariff#Reuters Roche#tariff announcement
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting - Nature
#Salmonella Typhi#Leveraging illumina#genome sequencing#resource-limited setting#Nature Leveraging
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance
#Synaffix Collaborates#Qurient Therapeutics#Enable Development#Yahoo Finance#Lonza Synaffix
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
#obesity player#Roche targets#experimental drug#drug enters#enters late-stage
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire
#Engages Lonza#Scale Manufacturing#Manufacturing Exosome#Exosome Based#RION Engages
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma
#RION Partners#Drug Manufacturing#Contract Pharma#Scalable Exosome-Based#Exosome-Based Drug
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Scale Manufacturing#Lonza Agrees#Therapeutics GEN#Exosome-Based Therapeutics
Geriatrician Roche appointed Professor Emeritus of Internal Medicine - UT Southwestern Medical Center
#Professor Emeritus#Southwestern Medical#Internal Medicine#Medical Center#Geriatrician Roche
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#myeloma target#Roche pushes#Pipeline Roche
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech
#Fierce Biotech#obesity ambition#Biotech Roche#megablockbuster Fierce#top
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#Pipeline Roche#ApexOnco#analysis Oncology
Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma
#develop KRAS#KRAS companion#multiple pharma#companion diagnostics#pharma partners
Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire
#Illumina advances#advances personalized#personalized cancer#cancer care#pharma development